Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | HTR2A | P28223 | 3/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.49 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9734378 | 1.00 | TAAR1 (0.52) | TAAR1HTR2ACHRNB2CHRNA4NOS2 | |
| SCHEMBL5967321 | 1.00 | TAAR1 (0.52) | TAAR1HTR2ACHRNB2CHRNA4NOS2 | |
| Hydrochloric Acid SCHEMBL20746350 | 0.98 | TAAR1 (0.50) | TAAR1HTR2ACHRNB2CHRNA4NOS2 | |
| SCHEMBL2871199 | 0.88 | CHRNB2 (0.57) | TAAR1HTR2ACHRNB2CHRNA4 | |
| SCHEMBL6336591 | 0.83 | HRH1 (0.56) | TAAR1HTR2ANOS2HRH1SLC6A2 | |
| SCHEMBL6343043 | 0.81 | SLC6A4 (0.41) | TAAR1HTR2AHRH1SLC6A2SLC6A4 | |
| SCHEMBL13569341 | 0.80 | AOC3 (0.42) | TAAR1 | |
| SCHEMBL13569343 | 0.80 | AOC3 (0.42) | TAAR1 | |
| SCHEMBL18257696 | 0.80 | AOC3 (0.42) | TAAR1 | |
| SCHEMBL8269660 | 0.79 | LMNA (0.48) | TAAR1HTR2AHRH1SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114420852-B | Preparation method of pure-phase RP perovskite film | 河北工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-114824092-B | Solar cell based on quasi-two-dimensional perovskite and preparation method thereof | 北京炎和科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-116554862-A | Zinc-based metal halide room-temperature phosphorescent material, and preparation method and application thereof | 南京邮电大学 | 2023-08-08 | — | — | CN | claimed |
| CN-114824092-A | Solar cell based on quasi two-dimensional-two-dimensional perovskite and preparation method thereof | 河北工业大学 | 2022-07-29 | — | — | CN | claimed |
| WO-2021181360-A1 | NOVEL SALTS OF QUINOLONE COMPOUNDS | CADILA HEALTHCARE LIMITED (IN) | 2021-09-16 | — | — | WO | claimed |
| CN-103717604-B | Replace aminooimidazole and pyridazine | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-01 | — | — | CN | claimed |
| CN-103717604-A | Substituted aminoimidazopyridazines | BAYER IP GMBH | 2014-04-09 | — | — | CN | claimed |
| EP-1487795-B1 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC (CA) | 2010-11-03 | — | — | EP | claimed |
| US-7563910-B2 | Heterocyclic cannabinoid receptor antagonists | HOFFMANN-LA ROCHE INC. (US) | 2009-07-21 | — | — | US | claimed |
| EP-1749002-B1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | HOFFMANN LA ROCHE (CH) | 2009-05-27 | — | — | EP | claimed |
| EP-1749002-A1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | F.HOFFMANN-LA ROCHE AG (CH) | 2007-02-07 | — | — | EP | claimed |
| US-7135570-B2 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC. (CA) | 2006-11-14 | — | — | US | claimed |
| WO-2005108393-A1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-17 | — | — | WO | claimed |
| US-20050250769-A1 | Heterocyclic cannabinoid receptor antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-10 | — | — | US | claimed |
| US-20050080267-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED, INC. (CA) | 2005-04-14 | — | — | US | claimed |
| EP-1487795-A4 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC (CA) | 2005-02-09 | — | — | EP | claimed |
| EP-1487795-A2 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC. (CA) | 2004-12-22 | — | — | EP | claimed |
| US-20030114679-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED CORPORATION (CA) | 2003-06-19 | — | — | US | claimed |
| WO-2003022785-A2 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC. (CA) | 2003-03-20 | — | — | WO | claimed |
| CN-115803318-B | Method for preparing a compound | 拜耳公司 | 2026-05-19 | — | — | CN | disclosed |
| EP-4731689-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4200351-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200353-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200352-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4448605-B1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-12466913-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-11 | — | — | US | disclosed |
| US-12378348-B2 | Method for the production of a thermoplastic polyoxazolidinone | COVESTRO DEUTSCHLAND AG (DE) | 2025-08-05 | — | — | US | disclosed |
| CN-114824092-B | Solar cell based on quasi-two-dimensional perovskite and preparation method thereof | 北京炎和科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20250043061-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-02-06 | — | — | US | disclosed |
| WO-2024260858-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2024-12-26 | — | — | WO | disclosed |
| EP-4448605-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2024-10-23 | — | — | EP | disclosed |
| CN-118401580-A | Process for producing thermoplastic polyoxazolidinones | 科思创德国股份有限公司 | 2024-07-26 | — | — | CN | disclosed |
| EP-4255947-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-07-03 | — | — | EP | disclosed |
| CN-118103377-A | Compounds constituting C20 modified salinomycin derivatives, process for obtaining the compounds, compositions containing the compounds and uses of said compounds | 菲莱克洛有限责任公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117560937-A | Perovskite solar cell based on 3-methoxy phenethylamine passivating agent and preparation method thereof | 常州大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-117486879-A | Bay-substituted perylene diimide derivative and preparation method thereof | 山东大学 | 2024-02-02 | — | — | CN | disclosed |
| US-20240026065-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-01-25 | — | — | US | disclosed |
| EP-4255947-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | Covestro Deutschland AG (DE) | 2023-10-11 | — | — | EP | disclosed |
| EP-3757094-B1 | AMIDINE CATALYST FOR CURABLE COMPOSITIONS | SIKA TECH AG (CH) | 2023-10-11 | — | — | EP | disclosed |
| US-20230312486-A1 | POLYMORPHIC FORMS OF A ROR INHIBITING COMPOUND AND PROCESSES FOR ITS PREPARATION | GLENMARK SPECIALTY S.A. (CH) | 2023-10-05 | — | — | US | disclosed |
| US-20230279175-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2023-09-07 | — | — | US | disclosed |
| US-20230257512-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2023-08-17 | — | — | US | disclosed |
| CN-116554862-A | Zinc-based metal halide room-temperature phosphorescent material, and preparation method and application thereof | 南京邮电大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-116529281-A | Process for producing thermoplastic polyoxazolidone polymers | 科思创德国股份有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20230220144-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2023-07-13 | — | — | US | disclosed |
| EP-4208449-A1 | POLYMORPHIC FORMS OF A RORGAMMA INHIBITING COMPOUND AND PROCESSES FOR ITS PREPARATION | Glenmark Specialty S.A. (CH) | 2023-07-12 | — | — | EP | disclosed |
| EP-4200353-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2023-06-28 | — | — | EP | disclosed |
| EP-4200352-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2023-06-28 | — | — | EP | disclosed |
| EP-4200351-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2023-06-28 | — | — | EP | disclosed |
| WO-2023110515-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | WO | disclosed |
| EP-4194475-A1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2023-06-14 | — | — | EP | disclosed |
| CN-112480062-B | 5-lipoxygenase activating protein activity inhibitor and preparation method thereof | 陕西中医药大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115989262-A | Process for producing thermoplastic polyoxazolidinones | 科思创德国股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115989260-A | Method for producing thermoplastic polyoxazolidinones | 科思创德国股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115989261-A | Process for producing thermoplastic polyoxazolidinones | 科思创德国股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115368824-A | Fast curing migration-free compositions based on organic polymers containing silane groups | SIKA技术股份公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-114824092-A | Solar cell based on quasi two-dimensional-two-dimensional perovskite and preparation method thereof | 河北工业大学 | 2022-07-29 | — | — | CN | disclosed |
| WO-2022117443-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-09 | — | — | WO | disclosed |
| EP-4008736-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | Covestro Deutschland AG (DE) | 2022-06-08 | — | — | EP | disclosed |
| US-11292771-B2 | Amidine catalyst for curable compositions | SIKA TECHNOLOGY AG (CH) | 2022-04-05 | — | — | US | disclosed |
| WO-2022043125-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022043126-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022043127-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2022-03-03 | — | — | WO | disclosed |
| EP-3960785-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | Covestro Deutschland AG (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3960786-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXYZOLIDINONE | Covestro Deutschland AG (DE) | 2022-03-02 | — | — | EP | disclosed |
| EP-3960787-A1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2022-03-02 | — | — | EP | disclosed |
| CN-110546150-B | Pyrazolyl-containing tricyclic derivatives, preparation method and application thereof | 江苏豪森药业集团有限公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-112480062-A | 5-lipoxygenase activating protein activity inhibitor and preparation method thereof | 陕西中医药大学 | 2021-03-12 | — | — | CN | disclosed |
| EP-3483149-B1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | YUHAN CORP (KR) | 2021-01-13 | — | — | EP | disclosed |
| EP-3699179-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) | 2020-08-26 | — | — | EP | disclosed |
| EP-3699179-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) | 2020-08-26 | — | — | EP | disclosed |
| US-20200247815-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2020-08-06 | — | — | US | disclosed |
| US-20200247815-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2020-08-06 | — | — | US | disclosed |
| CN-110546150-A | Pyrazolyl-containing tricyclic derivatives, preparation method and application thereof | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD | 2019-12-06 | — | — | CN | disclosed |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | YUHAN CORPORATION (KR) | 2019-08-20 | — | — | US | disclosed |
| US-10344032-B2 | Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders | PÉCSI TUDOMÁNYEGYETEM (HU) | 2019-07-09 | — | — | US | disclosed |
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | YUHAN CORPORATION (KR) | 2019-05-16 | — | — | US | disclosed |
| EP-3483149-A1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Yuhan Corporation (KR) | 2019-05-15 | — | — | EP | disclosed |
| WO-2019076336-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2019-04-25 | — | — | WO | disclosed |
| WO-2019076336-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2019-04-25 | — | — | WO | disclosed |
| EP-3194399-B1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | PECSI TUDOMANYEGYETEM (HU) | 2019-04-10 | — | — | EP | disclosed |
| EP-2776489-B1 | EPOXY RESIN CURING AGENT WITH AROMATIC AMINO GROUPS | SIKA TECH AG (CH) | 2019-03-27 | — | — | EP | disclosed |
| CN-109135495-A | high solid coating and coating method | 巴斯夫涂料有限公司 | 2019-01-04 | — | — | CN | disclosed |
| EP-2776486-B1 | EPOXY RESIN CURING AGENT WITH PYRIDINYL GROUPS | SIKA TECH AG (CH) | 2018-09-26 | — | — | EP | disclosed |
| EP-2731979-B1 | CURING AGENT FOR EPOXY RESINS | SIKA TECH AG (CH) | 2018-08-22 | — | — | EP | disclosed |
| WO-2018140520-A1 | COMPOSITIONS AND PROCESS FOR STABILIZING PHENOLIC RESINS CONTAINING CALIXARENES | SI GROUP, INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| EP-2776490-B1 | HARDENERS FOR EPOXY RESIN COATINGS | SIKA TECH AG (CH) | 2018-02-28 | — | — | EP | disclosed |
| EP-3233790-A1 | CHEMICAL BLOWING AGENT AND THERMALLY EXPANDABLE THERMOPLASTIC COMPOSITION | Sika Technology AG (CH) | 2017-10-25 | — | — | EP | disclosed |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170260187-A1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | PÉCSI TUDOMÁNYEGYETEM (HU) | 2017-09-14 | — | — | US | disclosed |
| EP-3194399-A1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | Pécsi Tudományegyetem (HU) | 2017-07-26 | — | — | EP | disclosed |
| EP-2731927-B1 | LOW-EMISSION CURING AGENT FOR EPOXY RESINS | SIKA TECH AG (CH) | 2017-07-05 | — | — | EP | disclosed |
| CN-103874717-B | Firming agent for epoxy coating | SIKA技术股份公司 | 2016-12-14 | — | — | CN | disclosed |
| CN-103649161-B | Curing agent for epoxy resins | SIKA技术股份公司 | 2016-09-14 | — | — | CN | disclosed |
| US-9399697-B2 | Hardeners for epoxy resins, which comprise aromatic amino groups | SIKA TECHNOLOGY AG (CH) | 2016-07-26 | — | — | US | disclosed |
| US-9394230-B2 | Hardeners for epoxy resin coatings | SIKA TECHNOLOGY AG (CH) | 2016-07-19 | — | — | US | disclosed |
| US-9394399-B2 | Hardeners for epoxy resins, which comprise pyridinyl groups | SIKA TECHNOLOGY AG (CH) | 2016-07-19 | — | — | US | disclosed |
| WO-2016097365-A1 | CHEMICAL BLOWING AGENT AND THERMALLY EXPANDABLE THERMOPLASTIC COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2016-06-23 | — | — | WO | disclosed |
| CN-103717604-B | Replace aminooimidazole and pyridazine | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-01 | — | — | CN | disclosed |
| US-9346805-B2 | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2016-05-24 | — | — | US | disclosed |
| CN-103460086-B | Color composition for color filter and colour filter | TOYO INK SC HOLDINGS CO.,LTD. (JP) | 2016-05-18 | — | — | CN | disclosed |
| US-9340701-B2 | Curing agent for epoxy resin coatings | SIKA TECHNOLOGY AG (CH) | 2016-05-17 | — | — | US | disclosed |
| WO-2016042349-A1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | PÉCSI TUDOMÁNYEGYETEM (HU) | 2016-03-24 | — | — | WO | disclosed |
| US-9290609-B2 | Hardener for epoxy resins | SIKA TECHNOLOGY AG (CH) | 2016-03-22 | — | — | US | disclosed |
| EP-2776488-B1 | HARDENERS FOR EPOXY RESIN COATINGS | SIKA TECHNOLOGY AG (CH) | 2016-02-03 | — | — | EP | disclosed |
| CN-103649042-B | For the Low-emission hardener of epoxy resin | SIKA TECHNOLOGY AG (CH) | 2016-01-27 | — | — | CN | disclosed |
| US-9212287-B2 | Low-emission hardener for epoxy resins | SIKA TECHNOLOGY AG (CH) | 2015-12-15 | — | — | US | disclosed |
| CN-104710259-A | Synthesizing method for amide compound | UNIV ZHEJIANG TECHNOLOGY | 2015-06-17 | — | — | CN | disclosed |
| US-20140316080-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE PYRIDINYL GROUPS | SIKA TECHNOLOGY AG (CH) | 2014-10-23 | — | — | US | disclosed |
| US-20140309334-A1 | CURING AGENT FOR EPOXY RESIN COATINGS | SIKA TECHNOLOGY AG (CH) | 2014-10-16 | — | — | US | disclosed |
| US-8853230-B2 | Inhibitors of JAK | PORTOLA PHARMACEUTICALS, INC. (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140288247-A1 | HARDENERS FOR EPOXY RESIN COATINGS | SIKA TECHNOLOGY AG (CH) | 2014-09-25 | — | — | US | disclosed |
| US-20140275446-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE AROMATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2014-09-18 | — | — | US | disclosed |
| EP-2776490-A2 | HARDENERS FOR EPOXY RESIN COATINGS | Sika Technology AG (CH) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776486-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE PYRIDINYL GROUPS | Sika Technology AG (CH) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776488-A1 | HARDENERS FOR EPOXY RESIN COATINGS | Sika Technology AG (CH) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776489-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE AROMATIC AMINO GROUPS | Sika Technology AG (CH) | 2014-09-17 | — | — | EP | disclosed |
| CN-103819403-A | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | ARDELYX INC | 2014-05-28 | — | — | CN | disclosed |
| EP-2731927-A1 | LOW-EMISSION HARDENER FOR EPOXY RESINS | Sika Technology AG (CH) | 2014-05-21 | — | — | EP | disclosed |
| EP-2731979-A1 | HARDENER FOR EPOXY RESINS | Sika Technology AG (CH) | 2014-05-21 | — | — | EP | disclosed |
| US-20140128506-A1 | HARDENER FOR EPOXY RESINS | SIKA TECHNOLOGY AG (CH) | 2014-05-08 | — | — | US | disclosed |
| US-20140107313-A1 | LOW-EMISSION HARDENER FOR EPOXY RESINS | SIKA TECHNOLOGY AG (CH) | 2014-04-17 | — | — | US | disclosed |
| CN-103717604-A | Substituted aminoimidazopyridazines | BAYER IP GMBH | 2014-04-09 | — | — | CN | disclosed |
| CN-103460086-A | Colored composition for color filters, and color filters | TOYO INK SC HOLDINGS CO LTD | 2013-12-18 | — | — | CN | disclosed |
| US-20130137673-A1 | INHIBITORS OF JAK | PORTOLA PHARMACEUTICALS, INC. (US) | 2013-05-30 | — | — | US | disclosed |
| WO-2013068507-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE AROMATIC AMINO GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013068506-A1 | HARDENERS FOR EPOXY RESINS, WHICH COMPRISE PYRIDINYL GROUPS | SIKA TECHNOLOGY AG (CH) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013068502-A2 | HARDENERS FOR EPOXY RESIN COATINGS | SIKA TECHNOLOGY AG (CH) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013068501-A1 | HARDENERS FOR EPOXY RESIN COATINGS | SIKA TECHNOLOGY AG (CH) | 2013-05-16 | — | — | WO | disclosed |
| EP-2592098-A1 | Epoxy resin curing agent with pyridinyl groups | Sika Technology AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-2592100-A1 | Curing agent for epoxy resin coatings | Sika Technology AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-2592101-A1 | Curing agent for epoxy resin coatings | Sika Technology AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| EP-2592099-A1 | Epoxy resin curing agent with aromatic amino groups | Sika Technology AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| US-8435963-B2 | Weight loss compositions and uses thereof | ENERGY BEVERAGES LLC | 2013-05-07 | — | — | US | disclosed |
| US-8367689-B2 | Inhibitors of JAK | PORTOLA PHARMACEUTICALS, INC. (US) | 2013-02-05 | — | — | US | disclosed |
| WO-2013010842-A1 | LOW-EMISSION HARDENER FOR EPOXY RESINS | SIKA TECHNOLOGY AG (CH) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013010841-A1 | HARDENER FOR EPOXY RESINS | SIKA TECHNOLOGY AG (CH) | 2013-01-24 | — | — | WO | disclosed |
| EP-2546276-A1 | Curing agent for epoxy resins | Sika Technology AG (CH) | 2013-01-16 | — | — | EP | disclosed |
| EP-2546230-A1 | Low-emission curing agent for epoxy resins | Sika Technology AG (CH) | 2013-01-16 | — | — | EP | disclosed |
| EP-1608617-B1 | MUSCARINIC AGONISTS | LILLY CO ELI (US) | 2013-01-09 | — | — | EP | disclosed |
| US-8168668-B2 | Compounds | ASTRAZENECA AB (SE) | 2012-05-01 | — | — | US | disclosed |
| CN-102333759-A | Compounds and methods for inhibiting NHE-mediated antiport for the treatment of disorders associated with fluid retention or salt overload and gastrointestinal disorders | ARDELYX INC | 2012-01-25 | — | — | CN | disclosed |
| CN-101346382-B | Carbonylamino pyrrolopyrazoles, potent kinase inhibitors | PFIZER PROD INC | 2011-07-06 | — | — | CN | disclosed |
| US-7964623-B2 | Tricyclic benzopyrane compound | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964623-B2 | Tricyclic benzopyrane compound | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2011-06-21 | — | — | US | disclosed |
| CN-102060716-A | Ritodrine hydrochloride preparation method | HAINAN CHUNTCH PHARMACEUTICAL CO LTD | 2011-05-18 | — | — | CN | disclosed |
| US-20110039324-A1 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | GENENTECH, INC. (US) | 2011-02-17 | — | — | US | disclosed |
| US-20110005947-A1 | INHIBITORS OF JAK | PORTOLA PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| EP-2254890-A1 | PROCESS FOR THE DIASTEREOISOMERIC RESOLUTION OF 5-METHYLTETRAHYDROFOLIC ACID | Gnosis S.p.A. (IT) | 2010-12-01 | — | — | EP | disclosed |
| US-20100286202-A1 | New Compounds | ASTRAZENECA AB (SE) | 2010-11-11 | — | — | US | disclosed |
| WO-2010129802-A1 | INHIBITORS OF JAK | PORTOLA PHARMACEUTICALS, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| EP-1487795-B1 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC (CA) | 2010-11-03 | — | — | EP | disclosed |
| WO-2010100520-A1 | A PROCESS FOR PREPARATION OF PHENETHYLAMINE DERIVATIVE | HIKAL LIMITED (IN) | 2010-09-10 | — | — | WO | disclosed |
| EP-2208727-A1 | Diaryl ethers as opioid receptor antagonist | Eli Lilly & Company (US) | 2010-07-21 | — | — | EP | disclosed |
| US-20100151188-A1 | STRUCTURE HAVING ORGANIC-INORGANIC COMPOSITE LAYER AND METHOD OF MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100081626-A1 | WEIGHT LOSS COMPOSITIONS AND USES THEREOF | ENERGY BEVERAGES LLC | 2010-04-01 | — | — | US | disclosed |
| US-20100069374-A1 | Tricyclic benzopyrane compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100069374-A1 | Tricyclic benzopyrane compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100055390-A1 | MICROPHASE-SEPARATED STRUCTURE ON FLEXIBLE SUBSTRATE, AND METHOD OF MANUFACTURE THEREOF | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| US-7652008-B2 | 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7652008-B2 | 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-01-26 | — | — | US | disclosed |
| WO-2009103333-A1 | PROCESS FOR THE DIASTEREOISOMERIC RESOLUTION OF 5-METHYLTETRAHYDROFOLIC ACID | GNOSIS S.P.A. (IT) | 2009-08-27 | — | — | WO | disclosed |
| US-7563910-B2 | Heterocyclic cannabinoid receptor antagonists | HOFFMANN-LA ROCHE INC. (US) | 2009-07-21 | — | — | US | disclosed |
| US-7560463-B2 | Diaryl ethers as opioid receptor antagonists | ELI LILLY AND COMPANY (US) | 2009-07-14 | — | — | US | disclosed |
| EP-1749002-B1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | HOFFMANN LA ROCHE (CH) | 2009-05-27 | — | — | EP | disclosed |
| US-7531557-B2 | Diaryl ethers as opioid receptor antagonists | ELI LILLY AND COMPANY (US) | 2009-05-12 | — | — | US | disclosed |
| CN-101346382-A | Carbonylamino pyrrolopyrazoles, potent kinase inhibitors | PFIZER PROD INC (US) | 2009-01-14 | — | — | CN | disclosed |
| US-7452994-B2 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED, INC. (CA) | 2008-11-18 | — | — | US | disclosed |
| US-20080269296-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | BLANCO-PILLADO MARIA-JESUS | 2008-10-30 | — | — | US | disclosed |
| US-20080255152-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY | 2008-10-16 | — | — | US | disclosed |
| US-7381719-B2 | Diaryl ethers as opioid receptor antagonist | ELI LILLY AND COMPANY (US) | 2008-06-03 | — | — | US | disclosed |
| US-7378447-B2 | Muscarinic agonists | ELI LILLY AND COMPANY (US) | 2008-05-27 | — | — | US | disclosed |
| US-7332489-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2008-02-19 | — | — | US | disclosed |
| CN-101107565-A | Pattern forming material, pattern forming apparatus and permanent pattern forming method | FUJI PHOTO FILM CO LTD (JP) | 2008-01-16 | — | — | CN | disclosed |
| US-20080004262-A1 | Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-01-03 | — | — | US | disclosed |
| US-20080004262-A1 | Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-01-03 | — | — | US | disclosed |
| EP-1815860-A2 | Phosphate transport inhibitors | GENZYME CORPORATION (US) | 2007-08-08 | — | — | EP | disclosed |
| US-7238692-B2 | Medical devices employing triazine compounds and compositions thereof | REDDY US THERAPEUTICS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-05-03 | — | — | US | disclosed |
| US-20070060757-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC. (CA) | 2007-03-15 | — | — | US | disclosed |
| EP-1749002-A1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | F.HOFFMANN-LA ROCHE AG (CH) | 2007-02-07 | — | — | EP | disclosed |
| US-7169785-B2 | Methods and compositions of novel triazine compounds | REDDY US THERAPEUTICS, INC. (US) | 2007-01-30 | — | — | US | disclosed |
| US-20070021509-A1 | Phosphate transport inhibitors | JOZEFIAK THOMAS H | 2007-01-25 | — | — | US | disclosed |
| US-7135570-B2 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED INC. (CA) | 2006-11-14 | — | — | US | disclosed |
| US-7119120-B2 | Phosphate transport inhibitors | GENZYME CORPORATION (US) | 2006-10-10 | — | — | US | disclosed |
| EP-1454958-B1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEM CO LTD (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-20060217372-A1 | Diaryl ethers as opioid receptor antagonist | ELI LILLY AND COMPANY | 2006-09-28 | — | — | US | disclosed |
| US-20060178438-A1 | Muscarinic agonists | ELI LILLY AND COMPANY (IN) | 2006-08-10 | — | — | US | disclosed |
| EP-1677784-A1 | INDOLE ANTIVIRAL COMPOSITIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2006-07-12 | — | — | EP | disclosed |
| EP-1608617-A1 | MUSCARINIC AGONISTS | ELI LILLY AND COMPANY (US) | 2005-12-28 | — | — | EP | disclosed |
| WO-2005108393-A1 | PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-17 | — | — | WO | disclosed |
| US-20050250769-A1 | Heterocyclic cannabinoid receptor antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 2005-11-10 | — | — | US | disclosed |
| EP-1562595-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2005-08-17 | — | — | EP | disclosed |
| WO-2005034943-A1 | INDOLE ANTIVIRAL COMPOSITIONS AND METHODS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-04-21 | — | — | WO | disclosed |
| US-20050080267-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED, INC. (CA) | 2005-04-14 | — | — | US | disclosed |
| EP-1509497-A1 | CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES | Amgen Inc. (US) | 2005-03-02 | — | — | EP | disclosed |
| EP-1487795-A4 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC (CA) | 2005-02-09 | — | — | EP | disclosed |
| US-20050001349-A1 | Lactic acid polymer composition and molded object thereof | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-1487795-A2 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC. (CA) | 2004-12-22 | — | — | EP | disclosed |
| US-6825351-B2 | SELECTIVE HYDROGENATION OF AMINO-SUBSTITUTED FUSED BICYCLIC AROMATIC RING SYSTEM, PREPARATION OF RACEMIC AMINO SUBSTITUTED FUSED BICYCLIC RING SYSTEM VIA NITROSATION, ENZYMATIC RESOLUTION OF RACEMIC MIXTURE TO PRODUCE (R)- AND (S)-FORMS | ANORMED, INC. (CA) | 2004-11-30 | — | — | US | disclosed |
| WO-2004094363-A1 | MUSCARINIC AGONISTS | ELI LILLY AND COMPANY (US) | 2004-11-04 | — | — | WO | disclosed |
| EP-1465638-A2 | PHOSPHATE TRANSPORT INHIBITORS | GENZYME CORPORATION (US) | 2004-10-13 | — | — | EP | disclosed |
| EP-1454958-A1 | LACTIC ACID POLYMER COMPOSITION AND MOLDED OBJECT THEREOF | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-20040116351-A1 | Method for enhancing the natural reward system for exercise | FAST BALANCE, INC. | 2004-06-17 | — | — | US | disclosed |
| WO-2004026305-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST | ELI LILLY AND COMPANY (US) | 2004-04-01 | — | — | WO | disclosed |
| EP-1385494-A2 | AEROSOL COMPOSITIONS CONTAINING FORMOTEROL AND A STEROID SUCH AS E.G. BUDESONIDE OR FLUTICASONE FOR DELIVERY INTO THE LUNGS | Dey L.P. (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20040019113-A1 | Phosphate transport inhibitors | GELTEX PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | disclosed |
| WO-2003099776-A1 | CALCIUM RECEPTOR MODULATING ARYLALKYLAMINES | AMGEN INC. (US) | 2003-12-04 | — | — | WO | disclosed |
| EP-1140818-B1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMA INC (US) | 2003-09-10 | — | — | EP | disclosed |
| CN-1118464-C | Noval pyrimidine derivatives and process and preparing thereof | YUHAN CORP (KR) | 2003-08-20 | — | — | CN | disclosed |
| WO-2003057225-A2 | PHOSPHATE TRANSPORT INHIBITORS | GENZYME CORPORATION (US) | 2003-07-17 | — | — | WO | disclosed |
| US-20030114679-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | ANORMED CORPORATION (CA) | 2003-06-19 | — | — | US | disclosed |
| WO-2003022785-A2 | SYNTHESIS OF ENANTIOMERICALLY PURE AMINO-SUBSTITUTED FUSED BICYCLIC RINGS | ANORMED INC. (CA) | 2003-03-20 | — | — | WO | disclosed |
| WO-2002083113-A2 | AEROSOL COMPOSITIONS CONTAINING FORMOTEROL AND A STEROID SUCH AS E.G. BUDESONIDE OR FLUTICASONE FOR DELIVERY INTO THE LUNGS VIA NEBULIZATION | DEY, L.P. (US) | 2002-10-24 | — | — | WO | disclosed |
| EP-0741567-B1 | INHIBITION OF SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXY CARBAZOLE COMPOUNDS | BOEHRINGER MANNHEIM PHARM CORP (US) | 2002-10-16 | — | — | EP | disclosed |
| US-6329550-B1 | FOR THERAPY OF EMPHYSEMA, OSTEOPOROSIS, RHEUMATOID ARTHRITIS AND NEOPLASTIC DISEASES | AVENTIS PHARMACEUTICALS INC. | 2001-12-11 | — | — | US | disclosed |
| EP-1140818-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | Aventis Pharmaceuticals Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000040552-A1 | AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE | AVENTIS PHARMACEUTICALS INC. (US) | 2000-07-13 | — | — | WO | disclosed |
| CN-1251586-A | Noval pyrimidine derivatives and process and preparing thereof | YUHAN CORP (KR) | 2000-04-26 | — | — | CN | disclosed |
| US-5973076-A | MOLDING; CONTROLLING TEMPERATURE IN PRESENCE OF AN AMIDE COMPOUND | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0776933-B1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEM CO LTD (JP) | 1999-08-04 | — | — | EP | disclosed |
| US-5922697-A | Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins | WARNER-LAMBERT COMPANY (US) | 1999-07-13 | — | — | US | disclosed |
| US-5863879-A | POLYMER IS FORMED BY REACTING A POLYMER CONTAINING VINYLAMINE UNIT WITH COMPOUNDS CONTAINING ALDEHYDE OR KETO GROUPS AND OPTIONAL OTHER AMINE OR ALOCHOL CONTAINING COMPOUNDS SUCH AS AMINAL, HEMIAMINAL OR AMINAL ACETATE | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-26 | — | — | US | disclosed |
| EP-0756618-B1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AG (DE) | 1998-08-12 | — | — | EP | disclosed |
| EP-0776933-A1 | Polybutene-1 resin composition and a method of accelerating the crystal transformation | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |
| WO-1997012903-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR INHIBITING THE BINDING OF PROTEINS CONTAINING AN SH2 DOMAIN TO COGNATE PHOSPHORYLATED PROTEINS | WARNER-LAMBERT COMPANY (US) | 1997-04-10 | — | — | WO | disclosed |
| EP-0756618-A1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-02-05 | — | — | EP | disclosed |
| EP-0741567-A4 | — | BOEHRINGER MANNHEIM PHARM CORP (US) | 1996-12-04 | — | — | EP | disclosed |
| EP-0741567-A1 | INHIBITION OF SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXY CARBAZOLE COMPOUNDS | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION-SMITHKLINE BEECHAM CORPORATION LIMITED PARTNERSHIP NO. 1 (US) | 1996-11-13 | — | — | EP | disclosed |
| EP-0569842-B1 | Electrodeposition coating containing a urethane | HOECHST AG (DE) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995029221-A1 | DYE-TRANSFER INHIBITORS FOR DETERGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1995-11-02 | — | — | WO | disclosed |
| WO-1995014384-A1 | INHIBITION OF SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXY CARBAZOLE COMPOUNDS | BOEHRINGER MANNHEIM PHARMACEUTICALS (US) | 1995-06-01 | — | — | WO | disclosed |
| US-5393772-A | Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation | BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION (US) | 1995-02-28 | — | — | US | disclosed |
| US-5338419-A | Few surface defects on galvanized surfaces | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-08-16 | — | — | US | disclosed |
| EP-0590419-A1 | Process for preparing unsaturated amines | BASF Aktiengesellschaft (DE) | 1994-04-06 | — | — | EP | disclosed |
| EP-0569842-A1 | Electrodeposition coating containing a urethane | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-11-18 | — | — | EP | disclosed |
| EP-0253272-B1 | ADDITION COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-09-23 | — | — | EP | disclosed |
| US-5070159-A | DISPERSANTS FOR PIGMENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-12-03 | — | — | US | disclosed |
| EP-0237910-B1 | PROCESS FOR PRODUCING AZO DYESTUFFS | BAYER AG (DE) | 1990-05-30 | — | — | EP | disclosed |
| EP-0213522-B1 | USE OF AN AGENT FOR OBTAINING A CONSTANT LAYER THICKNESS IN CATHODIC ELECTRODIP LACQUERING | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-03-28 | — | — | EP | disclosed |
| US-4888055-A | REACTION PRODUCT OF PRIMARY MONOAMINE AND CYCLIC MONOCARBONATE | HOECHST AG (DE) | 1989-12-19 | — | — | US | disclosed |
| EP-0338498-A2 | Process for preparing fluorine-containing copolymers | DAIKIN INDUSTRIES, LIMITED (JP) | 1989-10-25 | — | — | EP | disclosed |
| US-4810783-A | Process for the preparation of azo dyestuffs having an aniline-type coupler by aminolysis of the appropriate ether group-containing compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1989-03-07 | — | — | US | disclosed |
| EP-0253272-A2 | Addition compounds, process for their preparation and their application | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-01-20 | — | — | EP | disclosed |
| EP-0237910-A2 | Process for producing azo dyestuffs | BAYER AG (DE) | 1987-09-23 | — | — | EP | disclosed |
| EP-0213522-A2 | Use of an agent for obtaining a constant layer thickness in cathodic electrodip lacquering | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-03-11 | — | — | EP | disclosed |
| US-4629737-A | HYPOGLYCEMIC AGENTS; DIETETICS | BEECHAM GROUP P.L.C. (GB) | 1986-12-16 | — | — | US | disclosed |
| EP-0099707-B1 | 2-AMINOETHYL ETHER DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1986-12-10 | — | — | EP | disclosed |
| EP-0099707-A1 | 2-Aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1984-02-01 | — | — | EP | disclosed |
| US-4419367-A | METHYLTHIO-OR METHOXYPHENETHYLAMINE, SEX | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1983-12-06 | — | — | US | disclosed |
| US-4383090-A | HIGH SPEED; COCURING AGENT OF POLYAMIDE-POLYLACTAM COPOLYMER; FILMS; CASTINGS; POTTING; ADHESIVES | DIAMOND SHAMROCK CORPORATION (US) | 1983-05-10 | — | — | US | disclosed |
| US-4191765-A | 1-Aryloxy-2-hydroxy-3-aminopropanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-03-04 | — | — | US | disclosed |
| US-4191765-A | 1-Aryloxy-2-hydroxy-3-aminopropanes | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (25 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069374-A1 | Tricyclic benzopyrane compound | CBR1, CBR3, CYP2C9 | TAAR1 998/4885HTR2A 2403/4885CHRNB2 1105/4885 |
| US-20040019113-A1 | Phosphate transport inhibitors | SLC34A1, SLC34A2, SLC20A1 | TAAR1 864/4885HTR2A 1457/4885CHRNB2 3901/4885 |
| US-10344032-B2 | Agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders | TRPV1, P2RX3, P2RX7 | TAAR1 1030/4885HTR2A 450/4885CHRNB2 324/4885 |
| US-20060178438-A1 | Muscarinic agonists | CHRM3, CHRM1, CHRM5 | TAAR1 51/4885HTR2A 378/4885CHRNB2 22/4885 |
| US-20070099874-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | TAAR1 2382/4885HTR2A 1479/4885CHRNB2 4745/4885 |
| US-20030114679-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | CBR1, POR, CBR3 | TAAR1 533/4885HTR2A 1808/4885CHRNB2 1477/4885 |
| US-20080269296-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | OPRM1, OPRD1, OPRL1 | TAAR1 54/4885HTR2A 931/4885CHRNB2 679/4885 |
| US-20130137673-A1 | INHIBITORS OF JAK | JAK1, JAK2, JAK3 | TAAR1 2520/4885HTR2A 3796/4885CHRNB2 4884/4885 |
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | ILK, SBDS, BDKRB1 | TAAR1 3745/4885HTR2A 4659/4885CHRNB2 4357/4885 |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | ILK, SBDS, BDKRB1 | TAAR1 3745/4885HTR2A 4659/4885CHRNB2 4357/4885 |
| US-20140288247-A1 | HARDENERS FOR EPOXY RESIN COATINGS | EBPL, DPY30, BLK | TAAR1 3406/4885HTR2A 1831/4885CHRNB2 4584/4885 |
| US-20100286202-A1 | New Compounds | REN, PCSK9, FURIN | TAAR1 4096/4885HTR2A 3235/4885CHRNB2 4721/4885 |
| US-20050250769-A1 | Heterocyclic cannabinoid receptor antagonists | CNR1, CNR2, GPR18 | TAAR1 80/4885HTR2A 179/4885CHRNB2 581/4885 |
| US-20230312486-A1 | POLYMORPHIC FORMS OF A ROR INHIBITING COMPOUND AND PROCESSES FOR ITS PREPARATION | RORA, RORB, RORC | TAAR1 1223/4885HTR2A 1170/4885CHRNB2 277/4885 |
| US-20200247815-A1 | PYRAZOLYL-CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | MAPK1, MAPK11, MAPK14 | TAAR1 4503/4885HTR2A 4599/4885CHRNB2 4543/4885 |
| US-20070060757-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | CBR1, POR, CBR3 | TAAR1 533/4885HTR2A 1808/4885CHRNB2 1477/4885 |
| US-20080255152-A1 | DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS | OPRM1, OPRD1, OPRL1 | TAAR1 54/4885HTR2A 954/4885CHRNB2 669/4885 |
| US-20080004262-A1 | Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents | CBR1, CBR3, SCN8A | TAAR1 1212/4885HTR2A 2780/4885CHRNB2 1031/4885 |
| US-20110005947-A1 | INHIBITORS OF JAK | JAK1, JAK2, JAK3 | TAAR1 2520/4885HTR2A 3796/4885CHRNB2 4884/4885 |
| US-20050080267-A1 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings | CBR1, POR, CBR3 | TAAR1 533/4885HTR2A 1808/4885CHRNB2 1477/4885 |
| US-20060217372-A1 | Diaryl ethers as opioid receptor antagonist | OPRM1, OPRL1, OPRD1 | TAAR1 52/4885HTR2A 815/4885CHRNB2 657/4885 |
| US-11292771-B2 | Amidine catalyst for curable compositions | ADM2, GMNN, ARG1 | TAAR1 911/4885HTR2A 3676/4885CHRNB2 2996/4885 |
| US-20070021509-A1 | Phosphate transport inhibitors | SLC34A2, SLC34A1, SLC20A1 | TAAR1 2051/4885HTR2A 1977/4885CHRNB2 4059/4885 |
| US-20170260187-A1 | NEW AGENTS FOR TREATING NEUROGENIC INFLAMMATION AND NEUROPATHIC HYPERALGESIA RELATED DISORDERS | TRPV1, P2RX3, P2RX4 | TAAR1 923/4885HTR2A 375/4885CHRNB2 291/4885 |
| US-20170291885-A1 | METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN | ENY2, ENO1, IDH1 | TAAR1 2234/4885HTR2A 2502/4885CHRNB2 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.